You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Fieldable decontamination system for sensitive equipment
SBC: Clear Scientific, LLC Topic: CBD192002The ability for a warfighter to quickly and effectively decontaminate chemical and biological agents on sensitive equipment in the field can significantly improve the readiness and effectiveness of that warfighter. We propose to improve current decontamination technology based on hot air decontamination techniques, already at TRL 4, to enable the rapid and complete removal of threats from sensitiv ...
SBIR Phase I 2020 Department of DefenseOffice for Chemical and Biological Defense -
Intracranial Pressure Assessment and Screening System for Viral or Bacterial Infections (IPASS-VBI)
SBC: VIVONICS INC Topic: CBD192005Vivonics is proposing a novel approach to address the needs of a non-invasive and real-time system to measure intracranial pressure (ICP) to support development of medical countermeasures. The proposed Intracranial Pressure Assessment and Screening System for Viral or Bacterial Infections (IPASS-VBI) leverages Vivonics expertise in non-invasively assessing ICP in humans due to traumatic brain inju ...
SBIR Phase I 2020 Department of DefenseOffice for Chemical and Biological Defense -
Production of a stable recombinant human butyrylcholinesterase
SBC: Clear Scientific, LLC Topic: CBD192007Human butyrylcholinesterase (BChE) is an effective bioscavenger of organophosphates and has potential for acting as a pre-exposure prophylactic or post-exposure treatment for organophosphate (OP) nerve agents, such as sarin. Ideally, a single dose of BChE could be administered and protect the warfighter for days or even weeks while in combat. To be effective in a military setting, especially as a ...
SBIR Phase I 2020 Department of DefenseOffice for Chemical and Biological Defense -
Novel Medical Countermeasures for Opioid Intoxication
SBC: Clear Scientific, LLC Topic: CBD192008Synthetic opioids including fentanyl and its derivatives pose a serious threat to both civilians and warfighters. The serum half-life of the current FDA-approved antidote for acute opioid poisoning, naloxone, is shorter than that for fentanyl and its synthetic analogs, and thus does not provide effective protection against these threat agents. The mechanism of action of naloxone is by competitive ...
SBIR Phase I 2020 Department of DefenseOffice for Chemical and Biological Defense -
Long Duration, Novel Opioid Medical Countermeasure for Intramuscular Injection
SBC: EXTEND BIOSCIENCES INC Topic: CBD192008Threats using chemical and biological weapons are ever-evolving and expanding in scope, underscoring the need for preparedness; therefore, the development and procurement of medical countermeasures is a high priority for the US. The high availability of synthetic opioids, such as fentanyl and its derivatives, is a threat to both the civilian and military communities. Currently, long acting opioid ...
SBIR Phase I 2020 Department of DefenseOffice for Chemical and Biological Defense -
Dual Formulation of Atropine/Scopolamine with Enhanced Stability
SBC: Nano Terra, Inc. Topic: CBD181005The standard US military treatment for nerve agent exposure is application of up to three autoinjectors, each containing atropine sulfate and 2-pralidoxime, to counteract symptoms of nerve agent intoxication and restore acetylcholinesterase activity. This treatment increases survival rates after nerve agent exposure, however, seizures resulting from nerve agent poisoning are a common symptom that ...
SBIR Phase II 2020 Department of DefenseOffice for Chemical and Biological Defense -
3D Printed Manufacturing of Respiratory Protection
SBC: AKITA INNOVATIONS LLC Topic: CBD181001The principal benefit of this project will be the development of materials, processes and designs for the additive manufacture of air purifying respirators. Additive manufacture allows mass personalization of existing systems. For respirators, that design is the unique size and facial structure of each individual warfighter. The ability to personalize respirator design to each unique warfighter wi ...
SBIR Phase II 2020 Department of DefenseOffice for Chemical and Biological Defense -
Durable Stretch Barrier Materials
SBC: LaunchBay LLC Topic: CBD181003Chemical, Biological, Radioactive and Nuclear (CBRN) protective ensembles are widely used by the US Military and civilian first responders as the first line of defense for personnel working in contaminated environments. Many innovative products have been developed for the chemical protective clothing market in response to demand from the market place for improved performance. However, the need for ...
SBIR Phase II 2020 Department of DefenseOffice for Chemical and Biological Defense -
MicroLens Hyperspectral Imager for Standoff Chemical Detection
SBC: BODKIN DESIGN & ENGINEERING LLC Topic: CBD171002The research resulted in the development of a new approach to hyperspectral imaging utilizing Compressive Sensing. The newly conceived snapshot spectral imager will provide spectral data in a very compact package. It will be virtually indistinguishable from a standard infrared camera but with the added capability for spectral measurement. The camera will thus deliver chemical species information m ...
SBIR Phase II 2020 Department of DefenseOffice for Chemical and Biological Defense -
Immediate Decontamination Kit for Military Working Dogs in Fields
SBC: ZYMERON CORPORATION Topic: CBD192001Military Working Dogs (MWDs) provide a valuable asset to military troops, police, and other government agencies. In recent years, the increasing deployments of MWDs in different tactical environments make them encounter much higher risk from exposure to a range of hazardous chemicals, including chemical warfare agents (CWAs), toxic industrial chemicals (TICs), and narcotics. Since there is no prot ...
SBIR Phase I 2020 Department of DefenseOffice for Chemical and Biological Defense